Dealings in Securities by Directors, Prescribed Officers and the Company Secretary of the Company ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 “the Company” DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY OF THE COMPANY In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: DIRECTORS OF THE COMPANY Director : Stephen Bradley Saad Date of transaction : 22 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 24 426 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R4 562 212.56 Nature of interest : Direct beneficial Clearance obtained : Yes Director : Sean Matthew Capazorio Date of transaction : 22 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 15 546 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R2 903 633.69 Nature of interest : Direct beneficial Clearance obtained : Yes PRESCRIBED OFFICERS OF THE COMPANY Prescribed Officer : Michael Guy Attridge Date of transaction : 23 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 10 558 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R1 971 990.51 Nature of interest : Direct beneficial Clearance obtained : Yes Prescribed Officer : Lorraine Angela Hill Date of transaction : 26 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 12 236 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R2 285 402.15 Nature of interest : Direct beneficial Clearance obtained : Yes Prescribed Officer : Zizipho Mmango Date of transaction : 22 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 11 728 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R2 190 519.48 Nature of interest : Direct beneficial Clearance obtained : Yes PRESCRIBED OFFICER AND COMPANY SECRETARY OF THE COMPANY Prescribed Officer & Company Secretary : Reginald Haman Date of transaction : 22 September 2023 Nature of transaction : Acceptance of deferred incentive bonus shares (vesting after three years) Number of securities : 11 728 Class of securities : Ordinary shares Grant price : R186.7769 Value of Transaction : R2 190 519.48 Nature of interest : Direct beneficial Clearance obtained : Yes All acceptances of deferred bonus shares are deemed to be off-market trades. Durban 27 September 2023 Sponsor Investec Bank Limited Date: 27-09-2023 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.